Uncategorized
Pfizer acquires cancer treatment biotech firm Seagen for $43 billion
Pfizer has acquired Seattle-based cancer treatment biotech firm Seagen for $43 billion. In an announcement on Monday, Pfizer CEO Albert Bourla said the acquisition will enable the pharmaceutical giant to deliver Seagen’s cancer therapy to the world “at a scale
Pfizer has acquired Seattle-based cancer treatment biotech firm Seagen for $43 billion. In an announcement on Monday, Pfizer CEO Albert Bourla said the acquisition will enable the pharmaceutical giant to deliver Seagen’s cancer therapy to the world “at a scale […]